The Dangers of Ozempic, Wegovy, Rybelsus, and Other Weight Loss Drugs Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk, as well as similar weight loss drugs like Mounjaro and Trulicity, manufactured by Eli Lilly and Company, carry potentially serious health risks
Beyond the scale, semaglutide typically lowers HbA1c by 0.91.5% in type 2 diabetes and, in cardiovascular-risk studies, slashed progression to diabetes by nearly 80% in people with pre-diabetes
It might be due to your dose or how your body processes the medication
Its active ingredient, semaglutide, is a GLP-1 receptor agonist (the same class of drugs that includes tirzepatide and liraglutide)
DISCLAIMER : The content in this article is provided for informational purposes only and is not intended as medical advice, or as a substitute for the medical advice of a physician
Linking a new habit to something you already do, like walking after a meal, helps it become automatic over time